// App-Quantinova.ai

22 : Both Domain I and PEGylated Domain I of Beta-2-Glycoprotein I (β2GPI) are capable of inhibiting IgA APS antibody binding

Researchers

Presenter

  • Aylin Albay

Principal Investigators

  • Charis Pericleous

  • Bahar Artim-Esen

  • Vera M Ripoll

  • Ian Giles

  • Anisur Rahman

  • Thomas C R McDonnell

Medical Centers

  • Division of Medicine, University College London, London, UNITED KINGDOM

  • Imperial College Vascular Sciences, National Heart & Lung Institute, Imperial College London, London, UNITED KINGDOM

  • Division of Rheumatology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, London, TURKEY

Locations

  • United Kingdom

  • Turkey

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Cluster of differentiation 79A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved